Research ArticleClinical Investigation
Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer
Nils F. Trautwein, Sven Mattern, Martina Hinterleitner, Gerald Reischl, Ralf Schirrmacher, Volker Steger, Silvio Nadalin, Konstantin Nikolaou, Johannes Schwenck, Stephan Singer and Christian la Fougère
Journal of Nuclear Medicine May 2025, jnumed.125.269619; DOI: https://doi.org/10.2967/jnumed.125.269619
Nils F. Trautwein
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany;
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
Sven Mattern
3Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany;
Martina Hinterleitner
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
4Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
Gerald Reischl
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
6Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls University Tuebingen, Tuebingen, Germany;
Ralf Schirrmacher
7Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, Alberta, Canada;
Volker Steger
8Department of Thoracic and Cardiovascular Surgery, German Cardiac Competence Center, University Hospital Tuebingen, Tuebingen, Germany;
Silvio Nadalin
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
9Department of General, Visceral, and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany;
Konstantin Nikolaou
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
10Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany; and
11German Cancer Consortium, German Cancer Research Center, Partner Site Tuebingen, Tuebingen, Germany
Johannes Schwenck
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
6Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls University Tuebingen, Tuebingen, Germany;
Stephan Singer
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
3Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
Christian la Fougère
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany;
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
11German Cancer Consortium, German Cancer Research Center, Partner Site Tuebingen, Tuebingen, Germany

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer
Nils F. Trautwein, Sven Mattern, Martina Hinterleitner, Gerald Reischl, Ralf Schirrmacher, Volker Steger, Silvio Nadalin, Konstantin Nikolaou, Johannes Schwenck, Stephan Singer, Christian la Fougère
Journal of Nuclear Medicine May 2025, jnumed.125.269619; DOI: 10.2967/jnumed.125.269619
Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer
Nils F. Trautwein, Sven Mattern, Martina Hinterleitner, Gerald Reischl, Ralf Schirrmacher, Volker Steger, Silvio Nadalin, Konstantin Nikolaou, Johannes Schwenck, Stephan Singer, Christian la Fougère
Journal of Nuclear Medicine May 2025, jnumed.125.269619; DOI: 10.2967/jnumed.125.269619
Jump to section
Related Articles
Cited By...
- No citing articles found.